Literature DB >> 24506089

Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma - implications for therapeutic strategies and targeted therapies.

Hye Jin Chung1, Meera Mahalingam.   

Abstract

Angiogenesis, defined as new vessel growth from a pre-existing vessel, has been shown to be crucial for tumor survival and growth in several lineage-unrelated malignancies including melanoma. The concept of vasculogenic mimicry, a highly patterned microcirculation independent of angiogenesis, has also been described in melanoma. The prognostic value of vascular invasion, characterized by the presence of tumor cells within vascular channels, in melanoma remains controversial as in the current American Joint Committee on Cancer-staging system for melanoma vascular invasion is not included for microscopic staging purposes. This review summarizes contemporary understanding of these three processes i.e. angiogenesis, vasculogenic mimicry, and vascular invasion in an effort to uncover putative targets as therapeutic strategies in melanoma.

Entities:  

Mesh:

Year:  2014        PMID: 24506089     DOI: 10.1586/14737140.2014.883281

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  8 in total

1.  Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p.

Authors:  Yong Wang; Baocun Sun; Huizhi Sun; Xiulan Zhao; Xudong Wang; Nan Zhao; Yanhui Zhang; Yanlei Li; Qiang Gu; Fang Liu; Bing Shao; Jindan An
Journal:  Tumour Biol       Date:  2016-02-18

Review 2.  Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance.

Authors:  Anna Martinez-Cardús; Miguel Vizoso; Sebastian Moran; Jose Luis Manzano
Journal:  Ann Transl Med       Date:  2015-09

3.  Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models.

Authors:  Stephan Niland; Dorde Komljenovic; Jadranka Macas; Thilo Bracht; Tobias Bäuerle; Stefan Liebner; Johannes A Eble
Journal:  Oncotarget       Date:  2018-04-27

4.  Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.

Authors:  Ana Carolina Monteiro; Julienne K Muenzner; Fernando Andrade; Flávia Eichemberger Rius; Christian Ostalecki; Carol I Geppert; Abbas Agaimy; Arndt Hartmann; André Fujita; Regine Schneider-Stock; Miriam Galvonas Jasiulionis
Journal:  Mol Oncol       Date:  2019-05-25       Impact factor: 6.603

5.  Overexpression of Wnt5a promotes angiogenesis in NSCLC.

Authors:  Lingli Yao; Baocun Sun; Xiulan Zhao; Xueming Zhao; Qiang Gu; Xueyi Dong; Yanjun Zheng; Junying Sun; Runfen Cheng; Hong Qi; Jindan An
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

Review 6.  Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.

Authors:  Ana Cavaco; Maryam Rezaei; Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

7.  Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.

Authors:  Ting Xiao; Weilong Zhong; Jianmin Zhao; Baoxin Qian; Huijuan Liu; Shuang Chen; Kailiang Qiao; Yueyang Lei; Shumin Zong; Hongzhi Wang; Yuan Liang; Heng Zhang; Jing Meng; Honggang Zhou; Tao Sun; Yanrong Liu; Cheng Yang
Journal:  Cell Death Dis       Date:  2018-09-05       Impact factor: 8.469

Review 8.  Applicability of Plant Extracts in Preclinical Studies of Melanoma: A Systematic Review.

Authors:  Kamylla Rafaella Sena Albuquerque; Nívea Maria Pacheco; Thalia Del Rosario Loyo Casao; Fabiana Cristina Silveira Alves de Melo; Rômulo Dias Novaes; Reggiani Vilela Gonçalves
Journal:  Mediators Inflamm       Date:  2018-07-26       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.